AstraZeneca PLC (ZEGA) — Cash Flow-to-Debt Ratio
AstraZeneca PLC (ZEGA) has a Cash Flow-to-Debt Ratio of 0.07x as of September 2025, meaning its operating cash flow of €5.13 Billion could theoretically repay 0% of its total liabilities (€68.48 Billion) in one year. See AstraZeneca PLC free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AstraZeneca PLC Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for AstraZeneca PLC across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of AstraZeneca PLC.
Annual Cash Flow-to-Debt Ratio for AstraZeneca PLC (2014–2024)
Year-by-year debt coverage analysis for AstraZeneca PLC. Check ZEGA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | €11.86 Billion | €63.16 Billion | ▲ +12.3% |
| 2023 | 0.17x | €10.36 Billion | €61.95 Billion | ▲ +1.3% |
| 2022 | 0.17x | €9.81 Billion | €59.42 Billion | ▲ +82.9% |
| 2021 | 0.09x | €5.96 Billion | €66.08 Billion | ▼ -3.9% |
| 2020 | 0.09x | €4.80 Billion | €51.09 Billion | ▲ +48.0% |
| 2019 | 0.06x | €2.97 Billion | €46.78 Billion | ▲ +13.0% |
| 2018 | 0.06x | €2.62 Billion | €46.61 Billion | ▼ -26.7% |
| 2017 | 0.08x | €3.58 Billion | €46.71 Billion | ▼ -15.3% |
| 2016 | 0.09x | €4.14 Billion | €45.86 Billion | ▲ +13.0% |
| 2015 | 0.08x | €3.32 Billion | €41.55 Billion | ▼ -55.8% |
| 2014 | 0.18x | €7.06 Billion | €38.95 Billion | — |